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Abstract 
The present study was oriented towards microencapsulation of aspirin and the 
study of its release kinetics. The desired encapsulation was achieved by 
emulsion solvent evaporation method using ethyl cellulose (EC), cellulose 
acetate phthalate (CAP) and their mixture (1:1) of polymeric constituents. 
Characterization of the formulations was performed by size, shape, drug loading 
efficiency and in-vitro drug release analysis. The in-vitro release profiles from 
different polymeric microcapsules were applied on different kinetic models. The 
prepared microcapsules were found free flowing and almost spherical in shape 
with particle sizes ranging from 300–700µm, having a loading efficiency of 75–
85%. The best fit model with the highest correlation coefficient was observed in 
Higuchi model, indicating diffusion controlled principle. The n value obtained 
from Korsemeyer-Peppas model varied between 0.5–0.7, confirming that the 
mechanism of drug release was diffusion controlled. Comparative studies 
revealed that the release of aspirin from EC microcapsules was slower as 
compared to that of CAP and their binary mixture.  
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Introduction 
Acetylsalicylic acid (Aspirin) is a non-steroidal anti-inflammatory and antipyretic drug. It 
inhibits platelet aggregation and prolongs bleeding time. It is widely used for the relief of 
pain [1, 2]. It is a Cyclo-oxygenase-2 inhibitor and is amply used as analgesic and anti- 
inflammatory drug having a half-life of 15–20 minutes [3]. Aspirin has a direct irritant effect 
on gastric mucosa due to inhibition of prostaglandins and prostacyclins and thus causes 
ulceration, epigastric distress, and/or hemorrhage [4]. Sustained release formulation of 
aspirin would reduce the undesired side effects, reduce frequency of administration and 
improves patient compliance [5]. 
Encapsulation is a useful method for prolonging the drug release from dosage forms and 
reducing adverse effects [6–8].  
Microcapsules are composed of a polymer wall enclosing a liquid core or other body of 
material [9]. Microencapsulation can be achieved by a myriad of techniques. The emulsion 
solvent evaporation (ESE) method can be used to prepare microcapsules of water 
insoluble drug [10–13]. Moreover, addition of non-solvent also markedly affects the 
morphological and release kinetics of resultant particles [14, 15]. 
In this present study, Aspirin microcapsules were prepared by emulsion solvent 
evaporation technique using EC, CAP and their combination as a coating material [16, 17]. 
Ethanol and acetone were used for the preparation of microcapsules. The prepared 
microcapsules were evaluated for drug content, particle-size, SEM and for in-vitro drug 
release study. 
Results and Discussion 
Aspirin microcapsules were prepared by emulsion solvent evaporation (ESE) methods 
using ingredients as given in Table1.  
Tab.1.   Quantity of polymer, drug and the solvent 
Formulation Drug: 
Polymer 
Liquid Paraffin 
(ml) 
Acetone 
(ml) 
Ethanol 
(ml) 
CAP 
(gm) 
EC 
(gm) 
Aspirin:CAP  4:1  60  10 – 1  – 
Aspirin:EC 4:1 60  –  10 –  1 
Aspirin:CAP+EC 4:1  60  5  5  0.5  0.5 
N=3 
 
Morphology 
The developed microcapsules were found to be discrete, spherical, free flowing and white 
in colour. SEM was performed on the developed microcapsules to assess their surface 
and morphological characteristics as shown in figure 1. SEM studies revealed that the 
microcapsules are almost spherical in shape.    Release Kinetic Studies of Aspirin Microcapsules from Ethyl Cellulose, Cellulose Acetate Phthalate …  95 
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Fig. 1.   Scanning Electron Microscopy of aspirin microcapsules with polymers: (a) CAP, 
(b) EC and (c) EC+CAP 
Particle Size 
Particle size of developed formulations was determined by particle size analyzer 
(Mastersizer Hydro 2000MU). Particle size analyses of various formulations are presented 
in table 2. Studies revealed that EC based microcapsules were larger than CAP, and EC + 
CAP based microcapsules. This may be attributed to differences in evaporation rate and 
solubility index of polymers in respective solvents.  
Tab.2.   Particle size, % yield, Drug content and Entrapment efficiency of aspirin 
Microcapsules 
Property  CAP  EC  CAP + EC 
Particle size (μm) 378.05±30.4 389.02±25.4 210.24±26.6 
% Yield  93.86±2.4  91.78±4.5 90.80±3.5 
Drug content(gm)  3.418±0.1 3.233±0.15  3.087±0.18 
% Entrapment efficiency 85.45±4.3 80.82±5.2 77.17±3.2 
N=3 
 
Drug entrapment efficiency 
The yield of microcapsules was found in the range of 90–94 %. The drug content was 
found to be higher in CAP microcapsules followed by EC and CAP+EC as depicted in 96 V.  Dash  et al.:  
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(Table 2). The higher drug entrapment in CAP microcapsules was attributed to the 
percentage yield, nature and concentration of polymer in the internal phase.  
In-vitro drug release 
Aspirin release from the microcapsules was studied at pH-1.2 for 2 hrs followed by in 
acetate buffer at pH 6.0 for 7 hrs. The release profiles of microcapsules are graphically 
presented in Figure 2. Result revealed that the In-vitro drug release of aspirin at pH-1.2 for 
first two hours was very slow followed by instant release at pH-6.0. After seven hours of 
dissolution, the amount of drug release from the microcapsules containing EC as coating 
material was found to be the least, whereas in case of CAP microcapsule, the release of 
aspirin after two hours was maximum. Drug release from all the microcapsules followed 
first order kinetics. The order of aspirin release from the microcapsules containing various 
polymers followed CAP > CAP + EC > EC. The release pattern indicated that the drug was 
released at constant rate and controlled by more than one mechanism. 
Release of aspirin from all the polymeric microcapsules were slow and spread over longer 
period of time. The release of aspirin at pH-1.2 was very slow which could be due to poor 
solubility of the drug and polymer in acidic medium. After 2 hrs when the microcapsules 
were transferred to acetate buffer at pH-6.0, there was abrupt release of the drug 
indicating that the medium can diffuse into polymeric matrix and dissolve the drug. 
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Fig. 2.   Comparative Release Profile of aspirin Microcapsules with different polymers 
(EC, CAP and EC+CAP) 
Release Kinetics 
The release kinetics of aspirin from various formulations was determined by comparing 
their respective co-relation coefficients. aspirin release from the microcapsules followed 
first-order kinetics. The plot of log % drug remaining vs. time was found to be linear with 
correlation coefficient greater than that of the zero order kinetics (Table 3).    Release Kinetic Studies of Aspirin Microcapsules from Ethyl Cellulose, Cellulose Acetate Phthalate …  97 
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Tab. 3.   Correlation coefficient (R
2) and constant (K) of different kinetic models for 
aspirin microcapsules 
Zero order  First order  Higuchi 
equation 
Peppas equation  Microcapsule 
R
2 K 0 R
2 K 1 R
2 K H R
2 Kp  n 
CAP  0.899 0.225 0.969 0.004 0.974 5.19 0.978 2.61 0.514 
EC  0.935 0.245 0.955 0.004 0.944 5.45 0.922 3.47 0.644 
CAP & EC  0.924  0.236  0.964 0.004 0.963 5.34 0.953 3.01 0.581 
 
Table 3 shows the correlation coefficient of different kinetic models for aspirin 
microcapsules containing various polymers. Higuchi plots (Table 3) were found to be of 
highest linearity with correlation coefficient greater than that of the zero order kinetics and 
corresponded to that of the first order kinetics indicating that the drug release mechanism 
from these microcapsules was diffusion controlled and follow first order kinetics in 
simulated intestinal fluids. Studies revealed that release of aspirin from developed 
microcapsules was found to be very close to zero-order kinetics in simulated gastric fluid, 
indicating that the concentration was nearly independent of drug release. Moreover, in-
vitro release of aspirin from CAP microcapsules was best explained by Korsmeyer-Peppas 
equation indicated a good linearity (r
2=0.978). The release exponent n was 0.514, which 
indicates a coupling of the diffusion and erosion mechanism so called anomalous diffusion 
and may indicate that the drug release is controlled by more than one process. 
Furthermore, other formulations were also explained by Korsmeyer-Peppas equation and 
indicated that value of “n” in Peppas equation is 0.5 < n < 1.0, which implies that the drug 
follows non- Fickian transport. 
The results indicated that EC and CAP combination based formulation exhibited the 
slowest release rate in SGF followed by faster release in SIF. This may be due to the 
presence of ethyl cellulose on the surface of microcapsules during their formation. During 
the formation microcapsules with combination of EC and CAP, acetone evaporated very 
rapidly compared to ethanol, this may be the contributing factor for the coating of EC over 
CAP. Release kinetic studies also revealed that plain EC and combination of EC and CAP 
follow almost similar patterns. 
It can be concluded that emulsification/solvent evaporation technique is a reproducible and 
simple method for the preparation of aspirin microcapsules. It was found that the prepared 
microcapsules were spherical, free flowing, high percentage entrapment efficiency and 
high percentage yielding capacity. It can be concluded from this study that aspirin 
microcapsules could be made suitable for oral controlled drug delivery systems using 
cellulose acetate phthalate and ethyl cellulose as retardant materials. However, the in-vitro 
release characteristics of drug from the microcapsules are subject to confirmation in 
animal and human studies for concluding enhanced bioavailability and reduced dose 
frequency for improved patient compliance. 
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Experimental 
Materials 
Aspirin (Advent Research Centre, Mumbai), acetone, cyclohexane, hydrochloric acid, 
ammonium acetate, glacial acetic acid were purchased from E-Merck Ltd., Mumbai. 
Ethanol, Heavy liquid paraffin, ethyl cellulose, cellulose acetate phthalate and deionized 
water were purchased from Cosmochem, Pune. All chemicals used in the experiments 
were of analytical grade and purchased from their respective commercial sources. 
Method 
Microcapsules of ethyl cellulose containing aspirin were prepared by an emulsion-solvent 
evaporation method as reported by Nokhodchi and Farid, 2002 [18]. Aspirin microcapsules 
were prepared by dissolving polymers in an organic solvent to form a homogeneous 
polymer solution. The core material, aspirin was added in a thin stream of heavy liquid 
paraffin. The mixture was agitated using a propeller mixer with the rotation speed 
600rpm.The dispersed phase consisting of drug and polymer (CAP, EC and their binary 
mixtures) were immediately transformed into fine droplets, which subsequently solidified 
into rigid microcapsules due to solvent evaporation. The liquid paraffin was decanted, and 
the microcapsules were collected, washed twice in cyclohexane to remove any adhering 
oily phase (liquid paraffin), and was air dried for at least 12 h to obtain discrete 
microcapsules. The quantity of polymer, drug and the solvent used is given in Table 1. 
Scanning Electron Microscopy (SEM) studies 
The microcapsules were observed under scanning electron microscopy (JEOL, JSM-
6840LV, Japan). For SEM the microcapsules were mounted directly on SEM stub, using 
double sided sticking tape and coated with platinum under reduced pressure and then 
placed in scanning electron microscope. Photomicrographs of prepared formulations are 
shown in Figure 1. 
Particle size analysis 
The microcapsules were sieved by the standard sieves and arranged in such a manner 
that the coarsest remained at the top and finest at the bottom. After that the samples 
retained at the bottom were collected. These samples were determined by photon 
correlation spectroscopy using Malvern Zetasizer (Mastersizer Hydro 2000MU). The 
average of 22 measurements was used. All measurements were made at a constant 
scattering angle of 90° at 25°C. All the data analysis was performed in automatic mode. 
The results are recorded in Table 2. 
Determination of drug content, encapsulation efficiency and % yield in the 
microcapsules 
Microcapsules (100 mg) of aspirin were weighed and dissolved in 1000 ml 1N HCl by 
stirring for 30 minutes. The solution was filtered and the filtrate was analysed by 
appropriate dilution and used for determination of drug entrapment efficiency using the 
following relationship: 
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content   drug   percent   l theoretica
content   drug   percent   estimated
    efficiency   ion Encapsulat × =  
The percentage yield of the microcapsules was determined for drug and was calculated 
using the following equation: 
  100
M
M
    Yield
O
× =  
Where M is the weight of microcapsules and Mo is the total expected weight of drug and 
polymer. Drug content, encapsulation efficiency and yield for each formulation were 
reported in Table-2.  
In-vitro drug release studies 
Release of aspirin from the microcapsules was studied at 1.2 pH (900 ml) for the first 2 hrs 
and followed by in acetate buffer atF pH 6.0 (900 ml) upto 5 hrs using an USP XXIV single 
stage Dissolution Test Apparatus with a paddle stirrer at 50 rpm. 100 mg of microcapsules 
was properly weighed and taken in a pouch tied to a glass slide and was placed in 900 ml 
of dissolution fluid (pH-1.2) and maintained at 37 ± 0.2 ºC. At appropriate intervals (15, 30, 
60, 90, 120 mins), 5 ml of the sample was taken and filtered through 0.45 μm Millipore. 
The dissolution media was then replaced by 5 ml of fresh dissolution fluid to maintain a 
constant volume. After two hours, the pouch containing microcapsules was removed and 
placed in 900 ml of dissolution fluid containing acetate buffer (pH-6.0) and then samples 
were collected at an appropriate intervals (15, 30, 60, 120, 180, 240 and 300 mins) as 
mentioned above. The samples were then analyzed at 278.5 and 239.5 nm by Elico UV-
Visible Double beam Spectrophotometer at pH-1.2 and 6.0, respectively. In order to 
investigate the mode of release from microcapsules, the release data were analyzed using 
following mathematical models: Zero-order kinetic (equation 1); first-order kinetic (equation 
2); Higuchi equation (square-root of time equation, equation 3) [19]; and Peppas equation 
(equation 4) [20]. 
Eq. 1.    t k     Q o =  
Eq. 2.    () ( ) t k -   Q ln   Q - 100 ln 1 o =  
Eq. 3.   
2 / 1
Ht k     Q =  
Eq. 4.    ()
n
Pt k   Q/100   Log =  
In equations Q, the percent of drug released is at time t, Q0, the percent of drug remaining 
to release and k0, k1 and kH are the coefficients of the equations. kP is constant 
incorporating structural and geometric characteristics of the release device, and n is the 
release exponent indicative of the mechanism of release. 
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